Predictive performance of breast cancer index (BCI) and clinical treatment score post-5 years (CTS5) in the IDEAL study.

被引：0
作者：
Liefers, Gerrit-Jan
Noordhoek, Iris
Putter, Hein
Wong, Jenna
Siuliukina, Natalia
Zhang, Yi
Kranenbarg, Elma Meershoek-Klein
Duijm-de Carpentier, Marjolijn
Van De Velde, Cornelis J. H.
Schnabel, Catherine A.
Treuner, Kai
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Leiden Univ, Dept Med Stat, Med Ctr, Leiden, Netherlands
[3] Biotheranost Holog Co, San Diego, CA USA
[4] Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
545
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Comparison of CTS5 risk model and 21-gene recurrence score assay in large-scale breast cancer population and combination of CTS5 and recurrence score to develop a novel nomogram for prognosis prediction
    Wang, Changjun
    Xu, Ying
    Lin, Yan
    Zhou, Yidong
    Mao, Feng
    Zhang, Xiaohui
    Shen, Songjie
    Zhang, Yanna
    Sun, Qiang
    BREAST, 2022, 63 : 61 - 70
  • [22] Clinical Treatment Score Post-5 Years as a Tool for Risk Estimation of Late Recurrence in Thai Patients With Estrogen-Receptor-Positive, Early Breast Cancer: A Validation Study
    Dejthevaporn, Thitiya
    Patanayindee, Panchanin
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2023, 17
  • [23] Clinical validity of clinical treatment score 5 (CTS5) for estimating risk of late recurrence in unselected, non-trial patients with early oestrogen receptor-positive breast cancer
    Juliet Richman
    Alistair Ring
    Mitch Dowsett
    Ivana Sestak
    Breast Cancer Research and Treatment, 2021, 186 : 115 - 123
  • [24] Clinical validity of clinical treatment score 5 (CTS5) for estimating risk of late recurrence in unselected, non-trial patients with early oestrogen receptor-positive breast cancer
    Richman, Juliet
    Ring, Alistair
    Dowsett, Mitch
    Sestak, Ivana
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (01) : 115 - 123
  • [25] Clinical Treatment Score post-5 years as a predictor of late distant recurrence in hormone receptor-positive breast cancer: systematic review and meta-analysis
    Shrestha, Amber
    Cullinane, Carolyn
    Evoy, Denis
    Geraghty, James
    Rothwell, Jane
    Walshe, Janice
    McCartan, Damien
    McDermott, Enda
    Prichard, Ruth
    BRITISH JOURNAL OF SURGERY, 2022, 109 (05) : 411 - 417
  • [26] Clinical validity of CTS5 for late recurrence in Chinese patients with early HR-positive breast cancer
    Xu, Junnnan
    Sun, Tao
    CANCER RESEARCH, 2020, 80 (04)
  • [27] Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor-Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5
    Dowsett, Mitch
    Sestak, Ivana
    Regan, Meredith M.
    Dodson, Andrew
    Viale, Giuseppe
    Thuelimann, Beat
    Colleoni, Marco
    Cuzick, Jack
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (19) : 1941 - +
  • [28] Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL Trials
    Noordhoek, Iris
    Blok, Erik J.
    Kranenbarg, Elma Meershoek-Klein
    Putter, Hein
    Duijm-de Carpentier, Marjolijn
    Rutgers, Emiel J. T.
    Seynaeve, Caroline
    Bartlett, John M. S.
    Vannetzel, Jean-Michel
    Rea, Daniel W.
    Hasenburg, Annette
    Paridaens, Robert
    Markopoulos, Christos J.
    Hozumi, Yasuo
    Portielje, Johanneke E. A.
    Kroep, Judith R.
    van de Velde, Cornelis J. H.
    Liefers, Gerrit-Jan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (28) : 3273 - +
  • [29] Correlation between the Clinical Treatment Score Post 5 years (CTS5) and the Oncotype DX 21-gene recurrence score (ODX-RS); can we accurately predict patients who require extended adjuvant hormonal manipulation [90]
    Shrestha, A.
    Cullinane, C.
    Evoy, D.
    Geraghty, J.
    Rothwell, J.
    McCartan, D.
    Quinn, C.
    McDermott, E.
    Walshe, J.
    Prichard, R.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 6) : S245 - S245
  • [30] The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
    Tajiri, Wakako
    Ijichi, Hideki
    Takizawa, Katsumi
    Koi, Yumiko
    Masuda, Takanobu
    Ueo, Hiroki
    Koga, Chinami
    Nakamura, Yoshiaki
    Taguchi, Kenichi
    Okamoto, Masahiro
    Tokunaga, Eriko
    BREAST CANCER, 2021, 28 (01) : 67 - 74
12345